To report methodology and overall clinical, laboratory and radiographic characteristics for Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA) classifi cation criteria. Methods The preliminary Vienna 2005 consensus conference, which proposed preliminary criteria for paediatric vasculitides, was followed by a EULAR/ PRINTO/PRES -supported validation project divided into three main steps.
INTRODUCTION
The patient groups upon which the American College of Rheumatology (ACR) based the vasculitis classifi cation criteria did not include children. 1 2 However, since then paediatricians have relied on these and other adult-based criteria [3] [4] [5] [6] [7] for their patients. Although children/adolescents and adults with vasculitis share many signs and symptoms of disease, they differ in the relative frequency of some clinical manifestations and concomitant diseases. 8 9 Therefore, it cannot be assumed a priori that the classifi cation criteria developed for adults are suitable for children and adolescents.
In 2005 the vasculitis working group of the Paediatric Rheumatology European Society (PRES) proposed preliminary classifi cation criteria, for some of the most common childhood vasculitides 10 -namely, Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG), c-Takayasu arteritis (c-TA) and Kawasaki disease. Subsequently, with support from the European League Against Rheumatism (EULAR), the Paediatric Rheumatology International Trials Organisation (PRINTO) 11 and PRES, PRINTO/ PRES established a formal statistical validation process with a large-scale data collection that culminated in the fi nal 2008 Ankara Consensus Conference.
In this fi rst paper we describe the general methodology and overall clinical, laboratory and radiographic characteristics, while the specifi c details of the fi nal classifi cation criteria for each of the four vasculitides analysed (HSP, c-TA, c-PAN and c-WG) are reported in the accompanying paper. 12 from a group of experts in a particular fi eld, were used to attain the goals: the Delphi technique and nominal group technique (NGT). 13 14 The Delphi technique uses a series of well-defi ned mail questionnaires while NGT is a structured face-to-face meeting designed to facilitate reaching consensus, through round robin discussion. 7 15-22 The 2005 Vienna Consensus conference
The general objective was to reach a consensus on classifi cation criteria for childhood vasculitis, as previously described. 10 In brief, consensus (≥80%) was reached to base the general working classifi cation for childhood vasculitides on vessel size: predominantly large-, medium-or small-vessel vasculitis (granulomatous and non-granulomatous), and other vasculitides (box 1). Preliminary classifi cation criteria based on consensus discussion were proposed for HSP, c-PAN, c-WG, or c-TA and Kawasaki disease as reported by Ozen et al. 10 
Validation of the preliminary criteria
After obtaining consent from parent(s)/child and ethics committee approval (as required by the national law in each participating country), 97 PRINTO/PRES institutions in 36 countries (see complete list at the end of the paper) enrolled children with selected vasculitides, into a three-step study.
Step 1: Web-based data collection Inclusion criteria were children with age at diagnosis ≤18 years, diagnosed by their treating physician, as HSP, c-PAN, c-WG, c-TA or other c-primary systemic vasculitis (c-other). The other rarest forms of vasculitis (cryoglobulinaemic vasculitis, Churg-Strauss syndrome) were excluded because of their low prevalence while Kawasaki syndrome was excluded because it is under evaluation by another paediatric group (personal communication).
The fi ve-page, web-based case report form included demographic data, clinical diagnosis made by the attending physician, presence of signs/symptoms in 12 broad organs/systems (general, mucosa and skin, eye, ears/nose/throat, respiratory, cardiovascular, neurological, gastrointestinal, renal, genital, musculoskeletal, other features of active vasculitis) before or at the date of diagnosis and at least 3 months later (in this series data after diagnosis are not presented), laboratory values (antineutrophilic cytoplasmic antibody (ANCA) testing by immunofl uorescence/MPO/PR3, renal features, infl ammation indices, platelets), physician global assessment of disease activity on a 10 cm visual analogue scale, biopsy fi ndings (renal, skin, upper airway, other) and imaging reports (chest x-ray, CT scan, MRI, conventional, CT or MRI angiography fi ndings). A three-page glossary, adapted from the Birmingham Vasculitis Activity Score glossary, [23] [24] [25] provided defi nition of all items included in the case report forms. Data were abstracted by review of the clinical charts. Data collection was both retrospective for diagnosis before May 2007 and prospective for the remaining patients (fi gure 1).
Data entry was carried out online through the member area of the PRINTO website (http://www.printo.it, accessed 11 March 2010) on a secured https platform. The electronic forms contained some predefi ned rules to avoid errors and missing data, but were also reviewed for consistency by a dedicated PRINTO research assistant.
The aim was to collect data for approximately 150 patients with HSP, 50 with c-TA, 80 with c-PAN and 40 with c-WG using each group of vasculitis as comparator for the others. 2 These numbers were realistic projections of patient numbers required to provide reliable statistical analyses based on the relative frequencies of each disease.
Step 2: Classifi cation by consensus panel This step was included in order to further clean the original dataset collected, thus allowing a robust fi nal patient dataset on which to base statistical validation of the classifi cation criteria. Three physicians from the PRINTO international coordinating centre (NR, AP, GF) screened out all submitted cases. A total of 128 patients who did not fulfi l ACR or EULAR classifi cation criteria or were misclassifi ed 3 10 (so called 'diffi cult cases') but were nevertheless diagnosed by the treating physicians as HSP, c-PAN, c-WG, c-TA or c-other were retrieved; in addition, 152 randomly selected patients were added (38 HSP, 23 c-PAN, 41 c-WG, 50 c-TA). Using three Delphi webrounds, the representative subgroup of 280 were classifi ed by a panel of 11 paediatric rheumatologists/nephrologists into HSP, c-PAN, c-WG, c-TA or c-other. The panel was presented with the complete time-of-diagnosis case report in web-based form, but was blinded to the original diagnosis assigned by the treating physician. A consensus ≥80% within the 11 panellists was required to establish the fi nal classifi cation of each diffi cult case. Patients for whom consensus did not reach ≥80% in the fi rst round, were re-evaluated in the second and third rounds, where panellists were made aware of each other's evaluations and were allowed to engage in a web-based collegial discussion of the specifi c cases. All patients for whom consensus was not achieved (<80%) were excluded from further analysis. We then calculated the κ level of agreement, 26 
Statistics
Descriptive statistics, using the fi nal classifi cation criteria, were reported as means ± SD, whereas categorical variables were reported as absolute frequencies and percentages. Laboratory values were standardised based on the normal values provided by each local laboratory, as previously described. 16 Comparison of frequencies was made by the χ² or the Fisher exact text (post hoc with Bonferroni's correction), while comparisons of means were made by the analysis of variance (parametric or non-parametric) with post hoc comparisons (Scheffé or Dunn's test) as appropriate.
For each individual criterion/classifi cation defi nition, we calculated the sensitivity (ability to recognise patients with the particular disease calculated as number of patients positive attending physician diagnosis; we expected to fi nd a κ>0.8 (almost perfect agreement) 27 between the consensus panel and the treating physician. The expected almost perfect agreement was crucial in order to allow combination, in the third step, of both the diffi cult cases for whom the panellists reached classifi cation consensus and the remaining patients diagnosed by the referring physician (see fi gure 1). The fi nal diagnosis attribution for each child in the third step was given therefore by the consensus classifi cation or by the original treating physician diagnosis.
Step 3: Statistical and consensus evaluations An NGT consensus conference was convened in Ankara in October 2008, to discuss the statistical performance (frequency, sensitivity/specifi city, area under the curve (AUC) and κ level of agreement) of clinical/laboratory fi ndings (criteria) and of different classifi cation criteria (about 50 for each disease) for HSP, c-TA, c-PAN and c-WG. All classifi cation criteria tested were developed by the PRINTO international coordinating centre (NR, AP, GF) based on combinations of criteria derived from the literature (eg, ACR classifi cation criteria, Vienna childhood criteria, etc) or created ad hoc (eg, for HSP 2/5 criteria, 3/5 criteria, for the criterion/defi nition divided by the total number of patients with the disease) and specifi city (ability to exclude patients with other diseases calculated as number of patients negative for the criterion/defi nition divided by the total number of patients without the disease). Sensitivity and specifi city for either the individual criterion (eg, purpura for HSP), reported in the accompanying paper, 12 and the classifi cation defi nitions (eg, Vienna preliminary HSP criteria) were calculated using as 'gold standard' the fi nal disease consensus classifi cation or original treating physician diagnosis. Moreover, we evaluated in the second step, the agreement between the consensus panel classifi cation and the diagnosis made by the treating physician, and in the third step, the agreement between the defi nitions tested and the fi nal disease consensus panel or original diagnosis by the treating physician by means of the κ-coeffi cient, 26 Sample size calculation for the diagnostic accuracy study (study in which the main objective is to evaluate the diagnostic accuracy of clinical, laboratory and other variables for the chosen outcome-in this case classifi cation criteria; parameters for diagnostic accuracy are sensitivity, specifi city, AUC) was based on the assumption that the required minimum AUC of the receiving operating curves was 85% with standard error of 3.5% giving a sample of 60 pairs of patients (60 cases vs 60 controls) for each specifi c vasculitis. 28 Data were entered in an Access XP database and analysed with Excel XP (Microsoft), XLSTAT 6.1.9 Addinsoft, Statistica 6.0 (StatSoft), and Stata 7.0 (Stata Corporation).
RESULTS
Step 1: Web-based data collection Figure 1 shows the fi nal enrolment fi gures. Of the 1398 children enrolled, 860 (62%) were diagnosed by the treating physician as HSP, 172 (12%) as c-PAN, 67 (5%) as c-WG, 99 (7%) as c-TA and 200 (14%) as c-other. Of the patients with HSP, c-PAN, c-WG and c-TA entered in the PRINTO web system, 74 (5%) were excluded for the following multiple reasons: 19 were beyond age limit, eight had associated co-morbid conditions, nine had incomplete data and 45 were excluded by the consensus panel classifi cation (see step 2). Of the 200 remaining patients (c-other), 45 patients had cutaneous PAN; 14 microscopic polyangiitis; 13 were excluded by the consensus classifi cation exercise because consensus could not be reached (k<80%); and the remaining 128 were excluded because a specifi c diagnosis was not given by the treating physician (unknown form of vasculitis).
Step 2: Classifi cation by consensus panel A total of 280/1398 (20%) children enrolled in the web-based system were classifi ed by the consensus panel (fi gure 1 and table 1), blinded to the centre diagnosis. Three round robin web-based classifi cation cycles allowed consensus ≥80% to be reached for the classifi cation of 56 HSP, 38 c-PAN, 53 c-WG, 48 c-TA and 27 patients with c-other vasculitis. For the remaining 58 (20%) consensus was <80% and therefore these patients were discarded from further consideration (fi gure 1). Table 1 shows the grid of agreement for the four vasculitides, as well as the κ-coeffi cient between the consensus panel classifi cation and original patient diagnosis made by the treating physician. The overall κ-agreement was 0.79 (substantial, 95% CI 0.73 to 0.84) for the 280 patients classifi ed considered altogether. The κ-agreement was >0.8 (almost perfect agreement) for HSP, c-WG and c-TA and substantial (0.73) for c-PAN. These high levels of agreement justifi ed the combination of either the subgroup of patients classifi ed by the consensus panel and the remaining patients diagnosed by the treating physician into the next step.
Step 3: Statistical and consensus evaluations Sensitivity, specifi city, AUC and κ level of agreement (measured between each defi nition and the fi nal disease classifi cation) of the fi nal EULAR/PRINTO/PRES classifi cation defi nitions and the related individual criteria for the four childhood vasculitides are reported in the accompanying paper 12 and in an online supplementary table.
Demographic and clinical characterisation according to the fi nal EULAR/PRINTO/PRES classifi cation criteria
As shown in table 2,children with HSP had younger age at onset, younger age at fi rst visit and the shortest disease duration, followed sequentially by c-PAN, c-TA and c-WG. The time κ Statistics for agreements were computed separately for each of the c-vasculitis entities (treating physician vs consensus panel) and included also misclassifi ed cases (c-other and no consensus); κ levels of 0.61-0.8 are substantial, >0.8 identifi es an almost perfect agreement. 26 27 c-PAN, childhood polyarteritis nodosa; c-TA, c-Takayasu arteritis; c-WG, c-Wegener granulomatosis; HSP, Henoch-Schönlein purpura.
group.bmj.com on February 3, 2013 -Published by ard.bmj.com Downloaded from Table 2 Baseline demographic and clinical data for the 1124 patients considered in the fi nal analysis (see also fi gure 1)
HSP (N=827) c-PAN (N=150) c-WG (N=60) c-TA (N=87) p Values
Age at onset of signs or symptoms (years) group.bmj.com on February 3, 2013 -Published by ard.bmj.com Downloaded from from onset of signs or symptoms to diagnosis was shortest in HSP (0.1±0.3 years), followed by c-PAN and c-WG while the longest period was observed for c-TA (1.3±1.6 years). Patients were predominantly Caucasian (82%) (p values <0.0001 for all comparisons).
In table 3 are reported the absolute frequencies, percentage frequencies and related p values (all <0.0001 except testicular pain or tenderness equal to 0.019) of the signs/symptoms (individually or in combination) for the 1124 patients included in the fi nal analysis (data for the 59 c-other are not shown in the table). Signs/symptoms reported refer to those most frequently observed in each different form of vasculitis. General signs/ symptoms (malaise or fever) were more frequently observed in the three non-HSP systemic vasculitides 245 (82%) (122 c-PAN, 53 c-WG and 70 c-TA) and were less common in HSP 386 (47%). For mucosa and skin involvement, oral/nasal ulceration were typical of c-WG, occurring in 29 (48%) cases; purpura in 827 (100%) HSP, and to a lesser extent in c-PAN 68 (45%) and c-WG 14 (23%); while specifi ed forms of skin involvement (livedo/nodules/superfi cial or deep skin infarction) were observed mainly in c-PAN 104 (69%). Upper airway/laryngo-tracheo-bronchial involvement was more frequent in c-WG, occurring in 52 (87%), cardiovascular in c-TA 74 (85%) and neurological involvement in c-PAN 39 (26%). Gastrointestinal (mainly abdominal pain) and musculoskeletal complaints were evenly distributed among all four vasculitides. Table 4 shows the absolute values, percentage frequencies and related p values (all <0.0001) of the laboratory, biopsy and imaging data. ANCA positivity was reported mainly in c-WG (any ANCA in 90%). Systemic infl ammation, as measured by erythrocyte sedimentation rate or C-reactive protein, was most common in c-PAN, c-WG and c-TA 277 (combined mean 93%) as compared with patients with HSP 430 (52%). Renal involvement (haematuria/proteinuria, serum creatinine elevation, abnormal glomerular fi ltration rate) was most frequent in c-WG (68%), followed by HSP (33%) and c-PAN (29%). Deposition of IgA was present in 83/89 (93%) biopsies performed in HSP, small-/medium-size necrotising vasculitis 67/79 biopsies (85%) for c-PAN, while granulomatous infl ammation lesions were observed in 27/50 (54%) c-WG biopsies. Similarly, abnormal chest x-ray or CT fi ndings (nodules, cavities or fi xed infi ltrates) were mainly seen in 47/60 group.bmj.com on February 3, 2013 -Published by ard.bmj.com Downloaded from (78%) images available in c-WG. Angiography fi ndings demonstrated that aneurysms/stenosis of medium/small arteries were present in 64/79 (81%) images in c-PAN, while in c-TA aneurysms/stenosis of large arteries were present in 87/87 (100%) of the images available.
DISCUSSION
The results of this project allow the classifi cation of children with HSP, c-PAN, c-WG or c-TA, using different combinations of signs/symptoms, laboratory, biopsy and imaging reports. The proposed defi nitions robustly classify and discriminate patients with the specifi c type of vasculitis (sensitivity) and exclude a high proportion of patients with other diseases (specifi city).
After the ACR publication in 1990 paediatric researchers had to rely on classifi cation criteria developed for adult patients. Because of the peculiarities of childhood vasculitis and its observed differences from adult vasculitis, in 2005 the vasculitis working group of PRES decided to assess the applicability of adult-onset vasculitis classifi cation criteria in children, with a view to determining if new or modifi ed classifi cation criteria should be developed for children. Indeed, it was not the intention of the PRES working group to replace existing criteria for adult patients, but rather to formally evaluate if they apply to children, and to determine if changes in classifi cation were necessary.
The process started with a literature review and a consensusbased preliminary proposal, 10 followed by a formal validation process described in this paper. The large-scale data collection has been more successful in recruiting patient numbers than initially expected. Our validation process resembles the methodology followed by the ACR in part, since we collected a large series of paediatric cases to evaluate the sensitivity and specifi city of each individual criterion and several different combinations of the most sensitive and specifi c items. Our process differed from the ACR methodology in that we introduced, as 'gold standard' a blinded (to the original diagnosis assigned by the treating physician) consensus classifi cation of the most difficult cases (about 20% of the cases) by a panel of 11 experienced paediatric rheumatologists/nephrologists. The purpose of this blinded classifi cation exercise was to confi rm/exclude, with an unbiased revision, the diagnosis made by the patient's physician and to calculate the κ-agreement between the consensus panel and the treating physician. The results of the blinded evaluation showed almost perfect κ-agreement, justifying the combination into one single group of both the patients classifi ed by the consensus panel and the patients diagnosed by the primary treating physician. The almost perfect κ was also an indirect confi rmation that the diagnosis made by the treating physicians was consistent with the clinical presentation of each child as abstracted from the patients' charts.
The main advantage of this project is the large dataset sample analysed and the unique worldwide nature of the data collected, thus capturing a broad spectrum of cases and ensuring that the classifi cation criteria can be applied universally. A possible limitation is related to the exclusion from the analysis of about 15% of the children enrolled who were, however, scattered proportionally among all vasculitides. Also, to obtain a more homo geneous sample we excluded the cases of unclassifi ed vasculitides that will be more precisely characterised in future analysis.
In conclusion, EULAR/PRINTO/PRES propose validated definitions for the classifi cation of HSP, c-PAN, c-WG and c-TA, each of which demonstrates high sensitivity/specifi city and an almost perfect agreement with the fi nal consensus classifi cation or original treating physician diagnosis.
